Clinical Trial Update: Trial of Leptin Replacement Therapy in Patients With Lipodystrophy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating leptin replacement therapy in lipodystrophy patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Lipodystrophy
• Hypoleptinemia
• Insulin Resistance
• Partial Lipodystrophy

Drugs mentioned

• Leptin replacement therapy (leptin)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hypoleptinemia, Generalized Lipodystrophy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-03-05